-
Something wrong with this record ?
Quality of Life Measures in Aortic Stenosis Research: A Narrative Review
D. Frank, S. Kennon, N. Bonaros, M. Romano, C. Di Mario, DJ. van Ginkel, W. Bor, M. Kasel, O. Backer, V. Hachaturyan, CM. Lüske, J. Kurucova, P. Bramlage, R. Styra
Language English Country Switzerland
Document type Journal Article, Review
PubMed
37442111
DOI
10.1159/000531465
Knihovny.cz E-resources
- MeSH
- Aortic Valve Stenosis * MeSH
- Quality of Life MeSH
- Humans MeSH
- Surveys and Questionnaires MeSH
- Aged MeSH
- Heart Failure * MeSH
- Check Tag
- Humans MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
BACKGROUND: Elderly patients with aortic stenosis (AS) not only have a reduced life expectancy but also a reduced quality of life (QoL). The benefits of an AS intervention may be considered a balance between a good QoL and a reasonably extended life. However, the different questionnaires being used to determine the QoL were generally not developed for the specific situation of patients with AS and come with strengths and considerable weaknesses. The objective of this article was to provide an overview of the available QoL instruments in AS research, describe their strengths and weaknesses, and provide our assessment of the utility of the available scoring instruments for QoL measurements in AS. SUMMARY: We identified and reviewed the following instruments that are used in AS research: Short Form Health Survey (SF-36/SF-12), EuroQol-5D (EQ-5D), the Illness Intrusiveness Rating Scale (IIRS), the HeartQoL, the Kansas City Cardiomyopathy Questionnaire (KCCQ), the Minnesota Living with Heart Failure Questionnaire (MLHF), the MacNew Questionnaire, and the Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ). KEY MESSAGES: There is no standardized assessment of QoL in patients with AS. Many different questionnaires are being used, but they are rarely specific for AS. There is a need for AS-specific research into the QoL of patients as life prolongation may compete for an improved QoL in this elderly patient group.
Department of Cardiac Surgery Innsbruck Medical University Innsbruck Austria
Department of Cardiology Barts Heart Centre St Bartholomew's Hospital London UK
Department of Cardiology St Antonius Hospital Nieuwegein The Netherlands
Department of Cardiology University Heart Center University Hospital Zurich Zurich Switzerland
Department of Internal Medicine 3 Partner site Hamburg Kiel Lübeck Kiel Germany
Department of Psychiatry University Health Network Toronto Ontario Canada
Edwards Lifesciences Prague Czechia
Institute for Pharmacology and Preventive Medicine Cloppenburg Germany
Interventional Cardiology The Heart Center Rigshospitalet Copenhagen Denmark
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001317
- 003
- CZ-PrNML
- 005
- 20240213094538.0
- 007
- ta
- 008
- 240109s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000531465 $2 doi
- 035 __
- $a (PubMed)37442111
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Frank, Derk $u Department of Internal Medicine III (Cardiology, Angiology and Critical Care), UKSH University Clinical Center Schleswig-Holstein and DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, Kiel, Germany
- 245 10
- $a Quality of Life Measures in Aortic Stenosis Research: A Narrative Review / $c D. Frank, S. Kennon, N. Bonaros, M. Romano, C. Di Mario, DJ. van Ginkel, W. Bor, M. Kasel, O. Backer, V. Hachaturyan, CM. Lüske, J. Kurucova, P. Bramlage, R. Styra
- 520 9_
- $a BACKGROUND: Elderly patients with aortic stenosis (AS) not only have a reduced life expectancy but also a reduced quality of life (QoL). The benefits of an AS intervention may be considered a balance between a good QoL and a reasonably extended life. However, the different questionnaires being used to determine the QoL were generally not developed for the specific situation of patients with AS and come with strengths and considerable weaknesses. The objective of this article was to provide an overview of the available QoL instruments in AS research, describe their strengths and weaknesses, and provide our assessment of the utility of the available scoring instruments for QoL measurements in AS. SUMMARY: We identified and reviewed the following instruments that are used in AS research: Short Form Health Survey (SF-36/SF-12), EuroQol-5D (EQ-5D), the Illness Intrusiveness Rating Scale (IIRS), the HeartQoL, the Kansas City Cardiomyopathy Questionnaire (KCCQ), the Minnesota Living with Heart Failure Questionnaire (MLHF), the MacNew Questionnaire, and the Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ). KEY MESSAGES: There is no standardized assessment of QoL in patients with AS. Many different questionnaires are being used, but they are rarely specific for AS. There is a need for AS-specific research into the QoL of patients as life prolongation may compete for an improved QoL in this elderly patient group.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kvalita života $7 D011788
- 650 12
- $a aortální stenóza $7 D001024
- 650 12
- $a srdeční selhání $7 D006333
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kennon, Simon $u Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
- 700 1_
- $a Bonaros, Nikolaos $u Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria
- 700 1_
- $a Romano, Mauro $u Department of Thoracic and Cardiovascular Surgery, Department of Interventional Cardiology, Hôpital Privé Jacques Cartier, Massy, France
- 700 1_
- $a Di Mario, Carlo $u Structural Interventional Cardiology, Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy
- 700 1_
- $a van Ginkel, Dirk-Jan $u Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
- 700 1_
- $a Bor, Wilbert $u Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
- 700 1_
- $a Kasel, Markus $u Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland
- 700 1_
- $a Backer, Ole De $u Interventional Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark
- 700 1_
- $a Hachaturyan, Violetta $u Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
- 700 1_
- $a Lüske, Claudia M $u Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
- 700 1_
- $a Kurucova, Jana $u Edwards Lifesciences, Prague, Czechia
- 700 1_
- $a Bramlage, Peter $u Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
- 700 1_
- $a Styra, Rima $u Department of Psychiatry, University Health Network, Toronto, Ontario, Canada
- 773 0_
- $w MED00001053 $t Cardiology $x 1421-9751 $g Roč. 148, č. 6 (2023), s. 556-570
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37442111 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213094535 $b ABA008
- 999 __
- $a ok $b bmc $g 2049758 $s 1211011
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 148 $c 6 $d 556-570 $e 20230713 $i 1421-9751 $m Cardiology $n Cardiology $x MED00001053
- LZP __
- $a Pubmed-20240109